Study to Determine Racial and Gender Differences in Platelet Aggregation

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

60 participants

Study Classification

OBSERVATIONAL

Study Start Date

2005-05-31

Study Completion Date

2006-05-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to see if there is a racial and/or gender difference in platelet aggregation.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Evaluation of Hemostasis in Bleeding and Thrombotic Disorders

NCT00178594

Blood Coagulation Disorders, Inherited Thrombotic Disorder

RECRUITING

Changes in Bleeding and Clotting During the Menstrual Cycle

NCT00480545

Von Willebrand's Disorder Healthy

WITHDRAWN

Effects of Antibodies to White Blood Cells on Platelet Transfusion Patients

NCT00460122

Healthy Transfusion Reactions

COMPLETED

A Prospective Evaluation of Thromboelastography for Identifying Coagulopathy in Severely Injured Patients

NCT01228058

Coagulopathy

COMPLETED

Risk Factors for Hospitalization and Transfusion Criteria in Patients With Dengue Virus Infection

NCT07007585

Dengue Dengue Fever Dengue Fever With Warning Signs

RECRUITING

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Genetic variability of various components of the coagulation system has been reported. Data on racial and gender differences in platelet aggregation are lacking.

We hypothesize that there are significant racial and gender differences on aggregatory response of platelets to commonly used agonists to evaluate platelet function such as adenosine diphosphate (ADP), epinephrine, collagen and arachidonic acid.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Platelet Aggregation

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Study Time Perspective

PROSPECTIVE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Blood Draw

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Race of Caucasian, African American, or Hispanic

Exclusion Criteria

* Chronic medical conditions
* Tobacco use
* Regular non-steroidal anti-inflammatory use, aspirin use, or use of one of the other anti-platelet drugs.

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes